Delivery Order SPE2DB22D2206-SPE2DB24FHY43
Award Date
6/27/24
Potential Completion Date
6/28/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which...
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical supply product, with a completion date of June 10, 2024. This award is a delivery order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, which has a total potential value of up to $999,999,999.00 through December...
The Defense Logistics Agency (DLA) awarded a delivery order contract worth $4,647.12 to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. The IDC enables DLA to efficiently procure a comprehensive range of pharmaceutical...
This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,585.43, is a delivery order for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML medical products. The contract has an ultimate completion date of May 5, 2023 and is a firm fixed-price type. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,647.12 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award, valued at $4,647.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the...
This federal contract award, worth $8,699.50, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product, with a period of performance through November 2024. The contract is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a larger Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,906.08 firm fixed-price delivery order is for MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of November 26, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division, which serves as a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, awarded by the Defense Logistics Agency (DLA), is a Delivery Order with a Firm Fixed Price of $11,374.08 and an ultimate completion date of May 31, 2024. This contract is not designated as a set-aside. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $17,188.46, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The award is a delivery order contract for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product. The contract has an ultimate completion date of August 5, 2024 and is a firm fixed-price arrangement. Amerisourcebergen, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, has...